Vitadio develops software and online tools to help prevent and control diabetes.
Vitadio has raised $3.2M in total funding. The most recent round was Seed. The last funding was announced in September 2023.
Vitadio's investors include N1, Theras Group, Pilulka Lab, Jafam Holding, Peter Skrla.
Vitadio is headquartered in Prague, Czech Republic.
Vitadio develops software and online tools to help prevent and control diabetes.
Vitadio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vitadio — Funding & Investors." VCBacked, September 25, 2023, https://www.vcbacked.co/company/vitadio. Accessed September 15, 2026.
VCBacked. (2023). Vitadio — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/vitadio
{{cite web |title=Vitadio — Funding & Investors |url=https://www.vcbacked.co/company/vitadio |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated